Profiling difenoconazole and flusilazole resistance, fitness penalty and phenotypic stability in Venturia inaequalis

Like

Share this post

Choose a social network to share with, or copy the URL to share elsewhere

This is a representation of how your post may appear on social media. The actual post will vary between social networks

Read the paper

SpringerLink
SpringerLink SpringerLink

Profiling difenoconazole and flusilazole resistance, fitness penalty and phenotypic stability in Venturia inaequalis - Scientific Reports

Apple scab disease causes significant losses in apple crop production. In the north western Himalayas of India, the indiscriminate use of triazole fungicides to manage apple scab has led to the emergence of triazole-resistant strains of V. inaequalis. To investigate the resistance profile in three Venturia inaequalis populations collected from North, South and Central Kashmir, baseline sensitivity assays were conducted on 30 V. inaequalis isolates unexposed to any fungicides. The mean ED50 value and discriminatory dose of difenoconazole and flusilazole were determined to be 0.584, 0.15 µg ml−1 and 0.018, 0.02 µg ml−1 respectively. The assessment at these discriminatory doses revealed a major shift in sensitivity against both fungicides. The sequencing of conserved region-2 of CYP51A1 revealed that the resistant isolates have TTT (Phenylalanine) instead of TAT (Tyrosine) codon at position 133. Moreover, the same mutation was observed in some shifted isolates which confirmed that this mutation is not solely responsible for the development of resistance. From linear mixed-model regression analyses, the fitness parameters of resistant isolates were assessed which revealed that except for oxidative stress at 1 mm H2O2 (wherein a decreased micro colony growth linearly increases with resistance), there is no fitness cost associated with the development of resistance against difenoconazole and flusilazole. Meanwhile, the resistance against both fungicides is phenotypically stable. Consequently, it is speculated that these populations are unlikely to regain their sensitivity even in the absence of these frequently used fungicides.

Background of the Research  

The apple industry in the Northwestern Himalayas, particularly in Kashmir, is facing a critical challenge in managing Venturia inaequalis, the causal agent of apple scab. Despite the intensive use of fungicides, especially Demethylation Inhibitors (DMIs) like difenoconazole and flusilazole, disease control remains suboptimal. This inefficacy raises serious concerns about the development of fungicide resistance in V. inaequalis, necessitating a scientific investigation into resistance mechanisms and their implications.  

Continuous and excessive application of these fungicides has led to increased input costs, significantly lowering the benefit-cost (B:C) ratio for orchardists. Additionally, the overuse of DMIs has contributed to alarming health risks, with a noticeable rise in cancer cases in Kashmir, which researchers have linked to prolonged pesticide exposure. Beyond human health, the persistent application of these chemicals has resulted in environmental degradation, affecting soil microbiota, water quality, and overall ecosystem stability.  

Moreover, the high residue levels of these fungicides have severely impacted India's apple export potential due to stringent Maximum Residue Limit (MRL) regulations in international markets. Addressing these concerns, this research aims to assess the development of resistance in V. inaequalis against difenoconazole and flusilazole, providing a scientific basis for sustainable disease management strategies. The findings will help in formulating effective Integrated Disease Management (IDM) approaches, promoting the rational use of fungicides, and ensuring long-term sustainability in apple production.

Please sign in or register for FREE

If you are a registered user on Research Communities by Springer Nature, please sign in

Follow the Topic

Fungi
Life Sciences > Biological Sciences > Agriculture > Plant Pathology > Fungi
Fungi
Life Sciences > Biological Sciences > Plant Science > Plant Pathology > Fungi
Antimicrobial Resistance
Life Sciences > Biological Sciences > Biological Techniques > Synthetic Biology > Molecular Engineering > Antimicrobials > Antimicrobial Resistance

Related Collections

With collections, you can get published faster and increase your visibility.

Artificial intelligence and medical imaging

This collection seeks original research on AI in medical imaging, covering algorithm development, model building, performance, pathology, clinical application, and public health. Includes MRI, CT, ultrasound, PET, and SPECT.

Publishing Model: Open Access

Deadline: May 01, 2025

Artificial intelligence and precision medicine

This collection welcomes original research on AI and precision medicine, including biomarker validation, drug screening, big data processing, and AI-assisted decision making.

Publishing Model: Open Access

Deadline: Jun 25, 2025